ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a new approach for patients with certain lymphomas (Hodgkin, NK/T-cell, and others) that have returned or not responded to treatment. The therapy uses immune cells from healthy donors that are specially trained in the lab to attack cancer cells carryi…
Matched conditions: ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for tough lymphoma: stem cell transplant trial for Non-Responders
Disease control Recruiting nowThis study is for people with peripheral T-cell lymphoma whose cancer did not shrink or got worse after standard first treatment. It compares a stem cell transplant from a donor to other rescue treatments. The goal is to see which approach helps people live longer and control the…
Matched conditions: ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Scientists hunt for clues to tell apart two Look-Alike lymphomas
Knowledge-focused Recruiting nowThis study looks at rare lymphomas that are hard to tell apart under the microscope—some look like Hodgkin lymphoma but lack a key marker (PAX5), making them similar to another type called anaplastic large cell lymphoma (ALCL). Researchers will analyze tissue samples from 60 adul…
Matched conditions: ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC